Annexon (NASDAQ:ANNX) used its Investor Day presentation to outline the scientific rationale and clinical progress for ...
Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...
Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...
Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...
Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated macrophage/microglial activation - two key drivers of neuroinflammationMB0109 demonstrated ...
Distinguishing between bipolar disorder and schizophrenia is often difficult since the two conditions share many biological traits. A team at King’s College London identified separate genetic pathways ...
A new study by researchers at King's College London has split schizophrenia risk into two genetically distinct pathways. One is characterized by a shared genetic risk with bipolar disorder and ...
Researchers identify bone-forming cells as the driver of scoliosis caused by a genetic disorder, which can be prevented by medications. CHINA, January 14, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results